Glutamate-independent long-term depression in rat hippocampus by activation of GABAA receptors

Life Sciences

Volumn 58, Issue 13, 1996, Pages 1023-1030

  Akhondzadeh, Shahin ^a   Stone, Trevor W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adenosine; GABA; Long term depression; Muscimol

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 1-AMINO-1,3-DICARBOXYCYCLOPENTANE; 2 AMINO 3 PHOSPHONOPROPIONIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; 2-AMINO-3-PHOSPHONOPROPIONIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE; ALANINE; AMINO ACID RECEPTOR BLOCKING AGENT; CYCLOLEUCINE; DRUG DERIVATIVE; GLUTAMIC ACID; KYNURENIC ACID; MUSCIMOL; NEUROTOXIN; BICUCULLINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; ELECTROSTIMULATION; HIPPOCAMPUS; IN VITRO STUDY; KINETICS; MALE; NERVE CELL PLASTICITY; PHYSIOLOGY; PYRAMIDAL NERVE CELL; RAT; WISTAR RAT; ANIMAL TISSUE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; LEARNING; MEMORY; NONHUMAN; SYNAPTIC TRANSMISSION;

2-AMINO-5-PHOSPHONOVALERATE; ADENOSINE; ALANINE; ANIMALS; CYCLOLEUCINE; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HIPPOCAMPUS; KINETICS; KYNURENIC ACID; MALE; MUSCIMOL; NEURONAL PLASTICITY; NEUROTOXINS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

EID: 0029926398     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(95)02362-3     Document Type: Article

References (30)

1. D.O. HEBB. The organisation of behaviour. New York: Wiley (1949).
2. M. ITO. Annu. Rev. Neurosci 12 85-102 (1989).
3. P.K. STANTON and T.J. SEJNOWSKI. Nature. 339, 215-218 (1989).
4. X.D. YANG and D.S. FABER. Proc Natl Acad Sci USA 88 4299-4303 (1991).
5. D.J. LINDEN. Neuron 12 457-472 (1994).
6. S. POCKETT, N.H. BROOKS and L.J BINDMAN. Exp Brain Res 80 196-200 (1990).
7. ARTOLA and W. SINGER. Trends Neurosci 16 480-487(1993).
8. C.F. EKEROT and M. KANO. Brain Res 342 357-360 (1985).
9. D. DAHL and J.M. SARVEY. Proc Natl Acad Sci USA 864776-4780 (1989).
10. Y. YOSIMURA, T. TSUMOTO and A. NISHIGORI. NeuroReport 2 393-396 (1991).
11. J.C. HIRSCH and F. CREPEL. Science 255 730-733 (1992).
12. M. KANO and M. KATO. Nature 325 276-279 (1987).
13. V.A. ARONIADOU and T.J. TEYLER. Brain Res 562 136-143 (1991).
14. H. DANIEL, N. HEMART, D. JAILLARD. Exp Brain Res 90 327-331 (1992).
15. C.R. BRAHAM and B. SREBRO. Brain Res 405 100-107 (1987).
16. D.M. LONINGER, E.C. TYLER and A.J. MERRITT. Neurophysiol. 70 1937-1949 (1993).
17. X.D. YANG, J.A. CONNOR and D.S. FABER. J Neurophysiol 71 1586-1590 (1994).
18. G.L. COLLINGRIDGE and R. LESTER. Pharmacol Rev 40 143-210 (1989).
19. D.T. MONAGHAN, R.J. BRIDGEJ and C.W. COTMAN. Ann Rev. Pharmacol Toxicol 29 365-402 (1989).
20. D.D. SCHOEPP, J. BOCKAERT and F. SLADECZEK. Trends Pharmacol Sci 11 508-515 (1990).
21. R.J. MILLER. Trens Pharmacol Sci 12 365-367 (1991).
22. S. NAKANISHI. Science 258 597-603 (1992).
23. O.V. GARASCHUK, Y.N. KOVALCHUK and O.A. KRISHTAL. Eur J Pharmacol 212 305-306(1992).
24. J.W. GOH and M.A. MUSGAVE. Neuropharmacology 32 311-312 (1993).
25. U. STAUBLI and G. LYNCH. Brain Res 513 113-118 (1990).
26. M.Y. XIAO, H. WIGTROM and B. GUSTAFSSON. Eur J Neurosci 6 1055-1057 (1994).
27. M.D. MAJEWSKA, N.L. HARRISON, R.D. SCHWARTZ, J.L. BAKER AND S.M. PAUL. Science N Y 232 1004-1007 (1988).
28. J.A. PETERS, E.F. KIRKNESS, H. CALLACHANH, J.J. LAMBERT AND A.J. TURNER. Br J Pharmacol 94 1257-1269 (1988).
29. T.W. STONE and H.A. SIMMONDS. Kluwer Press, Dordrecht (1991).
30. T.W. STONE. Pharmacol. Revs 45 309-379 (1993).